Feb 12 (Reuters) - European chemicals maker dsm-firmenich DSFIR.AS reported fourth-quarter core earnings below market expectations on Thursday, days after it agreed the long-awaited sale of its animal health and nutrition unit.
The group's adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) were 478 million euros ($567 million) in the quarter, including discontinued operations from the previously combined businesses. That fell short of analysts' forecast of 488 million euros, a company-provided consensus showed.
($1 = 0.8429 euros)
(Reporting by Dimitri Rhodes in Gdansk, editing by Milla Nissi-Prussak)
((Dimitri.Rhodes@thomsonreuters.com ))